NCT04454840 Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis Status COMPLETED Phase EARLY_PHASE1
NCT04440644 Italian Validation of the Beaumont Behavioural Inventory (BBI) Status COMPLETED Phase N/A
NCT04428775 A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease Status TERMINATED Phase PHASE2
NCT04393467 Transcranial Static Magnetic Field Stimulation (tSMS) in Amyotrophic Lateral Sclerosis (ALS). Status UNKNOWN Phase NA
NCT04391361 The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS Status UNKNOWN Phase PHASE2
NCT04380649 Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People Status ACTIVE_NOT_RECRUITING Phase NA
NCT04363684 ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) Status RECRUITING Phase N/A
NCT04332198 Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA) Status UNKNOWN Phase NA
NCT04328675 Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China Status UNKNOWN Phase N/A
NCT04326283 Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE1/PHASE2
NCT04313166 Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001 Status COMPLETED Phase PHASE2
NCT04305639 The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)" Status COMPLETED Phase N/A
NCT04288856 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE1
NCT04259255 Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) Status UNKNOWN Phase N/A